Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study

NCT03244176 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

28

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lymphomas Non-Hodgkin's B-Cell

Interventions

DRUG: Avelumab

Sponsor

Austin Health

Collaborators

[object Object]